Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?

Overview of attention for article published in Journal of Neuroimmune Pharmacology, October 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 9,135 followers.

Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe? https://t.co/WUwT5dQByo

06 Oct 2020

Reply Repost Favourite

RT @ingentium_ms: Simvastatin Therapy in #MultipleSclerosis #MS Patients with Respect to Gut #microbiome-Friend or Foe? https://t.co/Urc2pv…

21 Oct 2019

Reply Repost Favourite

Simvastatin Therapy in #MultipleSclerosis #MS Patients with Respect to Gut #microbiome-Friend or Foe? https://t.co/Urc2pvdm0M

21 Oct 2019

Reply Repost Favourite

Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe? https://t.co/IxoLwOncb6

20 Oct 2019

Reply Repost Favourite

Simvastatin therapy in multiple sclerosis patients with respect to gut microbiome-friend or foe? - Toghi M et al. - https://t.co/4ycX3yioUW #microbiome

20 Oct 2019

Reply Repost Favourite